Cells were incubated with a mouse monoclonal antibody targeting the human transferrin receptor (Clone H68.4, #136800, Invitrogen, Eugene, OR) diluted to a final concentration of 2 g/mL in PBS overnight at 4 C
While Huntingtons disease is widely considered to be due to a gain-of-function toxic effect, it has been demonstrated through selective deletion of Htt in striatal projection neurons of mice that these neurons require Htt for motor regulation, synaptic development, cell health, and survival during aging ( Free copper enhances the aggregational toxicity of Htt (Lobato et al., 2024)
10.1016/j.jphs.2019.05.009 42 KhadrawyY
This approval makes Eli Lillys oral GLP-1 receptor agonist, to be marketed as Foundayo, the second GLP-1 drug for weight loss available in pill form, after Wegovy, which gained approval in December 2025
AOD-9604 Clinical Evidence Context AOD-9604 is unusual among research peptides because it actually completed real Phase 1 and Phase 2 clinical trials